Summary
The product Stenabolic 10 (SR-9009 10 mg), manufactured by Intex Pharma, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number T-19020, was submitted by Intex Pharma and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the concentration of SR-9009 at 8.47 mg, which is 15.3% below the labeled claim of 10 mg.
The testing process began on 8 October 2024, with the sample received on 22 October 2024, and analysis completed on 29 October 2024. While the results confirm the presence of the expected compound, the underdosing highlights the need for continuous monitoring. Scrutiny of manufacturer-submitted samples remains essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Intex Pharma
- Product Name: Stenabolic 10 (SR-9009 10 mg)
- Active Ingredient: SR-9009
- Batch Number: T-19020
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #51244
- Testing Ordered: 8 October 2024
- Sample Received: 22 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Intex Pharma (Manufacturer)
- Analysis Paid For By: Intex Pharma (Manufacturer)
Testing Results
- Specification: 10 mg (as stated on the label)
- Measured Concentration: 8.47 mg
- Accuracy: 84.7% (15.3% below the label claim)
Verification Details
Verification URL: https://janoshik.com/tests/51244_BDGCFLCPX1J7
Evaluation of Manufacturer-Submitted Testing
This analysis highlights that SR-9009 is present at 8.47 mg, which is below the expected concentration. While this deviation may not be critical, it underscores the importance of maintaining consistent dosing to ensure product efficacy. Since Intex Pharma submitted and funded the test, careful evaluation is needed to assess product consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple samples.
Conclusion
The analysis confirms that Stenabolic 10 (SR-9009 10 mg) contains 8.47 mg of SR-9009, which is 15.3% below the labeled claim. While this batch exhibits high purity, the lower concentration highlights the importance of further testing to ensure accurate dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
